Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. . Lancet 2020 Oct 5. pii: S0140-6736(20)32013.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2020 Oct 5. pii: S0140-6736(20)32013.
PMID: 33031764